Teva Pharmaceutical Industries Ltd (TEVA) insider trading

Every open-market stock purchase and sale by Teva Pharmaceutical Industries Ltd executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.

Insider activity at a glance

  • Roberto Mignone (Insider) and 5 others sold $15.7M in the last 90 days.
  • Last company insider buy: David R. McAvoy (Executive), $21K, 14 months ago.
  • Congress: Alan Armstrong bought $1K to $15K, 7 months ago.

Last 12 months: insiders bought $0 (0 buys) and sold $113M (46 sales). Last close $42.09 on Oct 30, 2026.

Recent TEVA insider trades

DateInsiderTradeValue
Sep 18, 2026Roberto Mignone (Insider)Sold$14.4M
Sep 18, 2026Brian Savage (C-suite exec)Sold$174K
Sep 18, 2026Brian Savage (C-suite exec)Bought (not open market)$156K
Sep 18, 2026Brian Savage (C-suite exec)Bought (not open market)$156K
Sep 18, 2026Brian Savage (C-suite exec)Sold$98.8K
Sep 18, 2026Brian Savage (C-suite exec)Sold$12.2K
Aug 21, 2026Amir Weiss (C-suite exec)Sold$261K
Aug 21, 2026Amir Weiss (C-suite exec)Sold$94.1K
Aug 21, 2026Amir Weiss (C-suite exec)Bought (not open market)$49K
Aug 21, 2026Amir Weiss (C-suite exec)Bought (not open market)$47.9K
Aug 21, 2026Ronit Satchi-Fainaro (Insider)Sold$15.5K
Aug 17, 2026Evan Lippman (VP)Sold$680K
Aug 5, 2026Tal Zvi Zaks (Insider)Sold$593
Aug 3, 2026Eric A Hughes (Insider)Sold$892K
Aug 3, 2026Placid Jover (Insider)Sold$447K
Aug 3, 2026Placid Jover (Insider)Bought (not open market)—
Aug 3, 2026Eric A Hughes (Insider)Bought (not open market)—
Aug 3, 2026Placid Jover (Insider)Bought (not open market)—
Aug 3, 2026Eric A Hughes (Insider)Bought (not open market)—
Jun 18, 2026Matthew Shields (VP)Sold$322K
Jun 11, 2026Eliyahu Sharon Kalif (CFO)Sold$3.6M
Jun 5, 2026Richard D Francis (CEO)Sold$211K
Jun 5, 2026Tal Zvi Zaks (Insider)Bought (not open market)—
Jun 5, 2026Roberto Mignone (Insider)Bought (not open market)—
Jun 5, 2026Chen Lichtenstein (Insider)Bought (not open market)—

Who's trading TEVA

Get free alerts when an insider at Teva Pharmaceutical Industries Ltd files a new trade →